AstraZeneca reports positive data from Phase III trial of Bevespi Aerosphere

AstraZeneca has reported positive top-line results from the Phase III PINNACLE 4 clinical trial of Bevespi Aerosphere to treat moderate to very severe chronic obstructive pulmonary disease (COPD).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news